Cut-off Points of Treatment Delay to Predict Poor Outcomes Among New Pulmonary Tuberculosis Cases in Dalian, China: A Cohort Study

References

• Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;393(10181):1642–1656. doi:10.1016/s0140-6736(19)30308-330904262
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Tuberculosis Report 2020. Geneva, Switzerland; 2020.
   Google Scholar
• World Health Organization. Global Tuberculosis Report 2021. Geneva, Switzerland; 2021.
   Google Scholar
• Floyd K, Glaziou P, Zumla A, Raviglione M. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. Lancet Resp Med. 2018;6(4):299–314. doi:10.1016/s2213-2600(18)30057-2
   PubMed Web of Science ®Google Scholar
• Wang LX, Zhang H, Ruan YZ, et al. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–2064. doi:10.1016/s0140-6736(13)62639-224650955
   PubMed Web of Science ®Google Scholar
• Storla DG, Yimer S, Bjune GA. Can treatment delay be utilized as a key variable for monitoring the pool of infectious tuberculosis in a population? J Infect Dev Ctries. 2010;4(2):83–90. doi:10.3855/jidc.21120212338
   PubMed Web of Science ®Google Scholar
• Teo AKJ, Singh SR, Prem K, Hsu LY, Yi SY. Duration and determinants of delayed tuberculosis diagnosis and treatment in high-burden countries: a mixed-methods systematic review and meta-analysis. Respir Res. 2021;22(1):251. doi:10.1186/s12931-021-01841-634556113
   PubMed Web of Science ®Google Scholar
• French CE, Kruijshaar ME, Jones JA, Abubakar I. The influence of socio-economic deprivation on tuberculosis treatment delays in England, 2000–2005. Epidemiol Infect. 2009;137(4):591–596. doi:10.1017/s095026880800111818687159
   PubMed Web of Science ®Google Scholar
• Wang JM, Fei Y, Shen HB, Xu B. Gender difference in knowledge of tuberculosis and associated health-care seeking behaviors: a cross-sectional study in a rural area of China. BMC Public Health. 2008;8354. doi:10.1186/1471-2458-8-354
   Web of Science ®Google Scholar
• Ma EB, Ren LP, Wang WS, et al. Demographic and socioeconomic disparity in knowledge about tuberculosis in inner Mongolia, China. J Epidemiol. 2015;25(4):312–320. doi:10.2188/jea.JE2014003325797599
   PubMed Web of Science ®Google Scholar
• Ou YJ, Luo ZZ, Mou JS, et al. Knowledge and determinants regarding tuberculosis among medical students in Hunan, China: a cross-sectional study. BMC Public Health. 2018:18730. doi:10.1186/s12889-018-5636-x.
   Web of Science ®Google Scholar
• Asres A, Jerene D, Deressa W. Delays to treatment initiation is associated with tuberculosis treatment outcomes among patients on directly observed treatment short course in Southwest Ethiopia: a follow-up study. Article. BMC Pulm Med. 2018;18:11.64. doi:10.1186/s12890-018-0628-2
   Web of Science ®Google Scholar
• Riccardi N, Alagna R, Motta I, et al. Towards ending TB: civil community engagement in a rural area of Senegal: results, challenges and future proposal. Infect Dis. 2019;51(5):392–394. doi:10.1080/23744235.2019.1572920
   PubMed Web of Science ®Google Scholar
• Chen CC, Chiang PH, Chen YH, Fan IC, Chan TC. Patient and health care system characteristics are associated with delayed treatment of tuberculosis cases in Taiwan. BMC Health Serv Res. 2019;19(1):846. doi:10.1186/s12913-019-4702-031744504
   PubMed Web of Science ®Google Scholar
• Getnet F, Demissie M, Assefa N, Mengistie B, Worku A. Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: systematic review and meta-analysis. BMC Pulm Med. 2017;17202. doi:10.1186/s12890-017-0551-y
   Web of Science ®Google Scholar
• Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health. 2008;815. doi:10.1186/1471-2458-8-15
   Web of Science ®Google Scholar
• Migliori GB, Thong PM, Alffenaar JW, et al. Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study. Eur Respir J. 2021;58(5):2101786. doi:10.1183/13993003.01786-202134446465
   PubMed Web of Science ®Google Scholar
• Casco N, Jorge AL, Palmero DJ, et al. Tuberculosis and COVID-19 co-infection: description of the global cohort. Eur Respir J. 2021. doi:10.1183/13993003.02538-2021
   Web of Science ®Google Scholar
• Golub JE, Bur S, Cronin WA, et al. Delayed tuberculosis diagnosis and tuberculosis transmission. Int J Tuberc Lung Dis. 2006;10(1):24–30.16466033
   PubMed Web of Science ®Google Scholar
• Xu L, Chongsuvivatwong V, Lu L, Geater A, Ren LJ. Dose-response relationship between treatment delay of smear-positive tuberculosis patients and intra-household transmission: a cross-sectional study. Trans Roy Soc Trop Med Hyg. 2008;102(8):797–804. doi:10.1016/j.trstmh.2008.04.02718513768
   PubMed Web of Science ®Google Scholar
• Tedla K, Medhin G, Berhe G, Mulugeta A, Berhe N. Delay in treatment initiation and its association with clinical severity and infectiousness among new adult pulmonary tuberculosis patients in Tigray, northern Ethiopia. BMC Infect Dis. 2020;20(1). doi:10.1186/s12879-020-05191-4
   Web of Science ®Google Scholar
• Virenfeldt J, Rudolf F, Camara C, et al. Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study. Article. BMJ Open. 2014;4(6):8.e004818. doi:10.1136/bmjopen-2014-004818
   Web of Science ®Google Scholar
• Ngabonziza JCS, Habimana YM, Decroo T, et al. Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda. Int J Tuberc Lung Dis. 2020;24(3):329-+. doi:10.5588/ijtld.19.0298
   Web of Science ®Google Scholar
• Gebreegziabher SB, Bjune GA, Yimer SA. Total delay is associated with unfavorable treatment outcome among pulmonary tuberculosis patients in West Gojjam Zone, Northwest Ethiopia: a Prospective Cohort Study. PLoS One. 2016;11(7):e0159579. doi:10.1371/journal.pone.015957927442529
   PubMed Web of Science ®Google Scholar
• Teo AKJ, Ork C, Eng S, et al. Determinants of delayed diagnosis and treatment of tuberculosis in Cambodia: a mixed-methods study. Infect Dis Poverty. 2020;9(1). doi:10.1186/s40249-020-00665-8
   Web of Science ®Google Scholar
• Angelo AT, Geltore TE, Asega T. Knowledge, attitude, and practices towards tuberculosis among clients visiting tepi general hospital outpatient departments, 2019. Infect Drug Resist. 2020;13:4559–4568. doi:10.2147/idr.S28728833376362
   PubMed Web of Science ®Google Scholar
• Du L, Zhang Y, Lv X, et al. Prevalence of multidrug-resistant tuberculosis in Dalian, China: a Retrospective Study. Infect Drug Resist. 2021;14:1037–1047. doi:10.2147/idr.S29461133758518
   PubMed Web of Science ®Google Scholar
• World Health Organization. Treatment of Tuberculosis Guidelines. World Health Organization; 2010.
   Google Scholar
• Bello S, Afolabi RF, Ajayi DT, et al. Empirical evidence of delays in diagnosis and treatment of pulmonary tuberculosis: systematic review and meta-regression analysis. BMC Public Health. 2019:19820. doi:10.1186/s12889-019-7026-4.
   Web of Science ®Google Scholar
• Kim SH, Min J, Cho JY, et al. Clinical profiles and outcomes of pulmonary tuberculosis patients with delayed treatment at a tertiary hospital in South Korea. Ann Palliat Med. 2021;10(3):2948–2957. doi:10.21037/apm-20-152133691443
   PubMed Web of Science ®Google Scholar
• Yang Q, Tong YQ, Yin X, et al. Delays in care seeking, diagnosis and treatment of patients with pulmonary tuberculosis in Hubei, China. Int Health. 2020;12(2):101–106. doi:10.1093/inthealth/ihz03631227831
   PubMed Web of Science ®Google Scholar
• Chandra A, Kumar R, Kant S, Krishnan A. Diagnostic pathways and delays in initiation of treatment among newly diagnosed tuberculosis patients in Ballabgarh, India. Am J Trop Med Hyg. 2021;104(4):1321–1325. doi:10.4269/ajtmh.20-1297
   Web of Science ®Google Scholar
• Wang XL, He WC, Lei J, Liu GT, Huang F, Zhao YL. Impact of COVID-19 pandemic on pre-treatment delays, detection, and clinical characteristics of tuberculosis patients in Ningxia Hui Autonomous Region, China. Front Public Health. 2021;9644536. doi:10.3389/fpubh.2021.644536
   Web of Science ®Google Scholar
• Haq K, McElhaney JE. Ageing and respiratory infections: the airway of ageing. Immunol Lett. 2014;162(1 Pt B):323–328. doi:10.1016/j.imlet.2014.06.00924973652
   PubMed Web of Science ®Google Scholar
• Rajagopalan S. Tuberculosis in Older Adults. Clin Geriatr Med. 2016;32(3):479–491. doi:10.1016/j.cger.2016.02.00627394018
   PubMed Web of Science ®Google Scholar
• Shu CC, Lee CH, Lee MC, Wang JY, Yu CJ, Lee LN. Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre. Int J Tuberc Lung Dis. 2013;17(7):934–939. doi:10.5588/ijtld.12.078223743313
   PubMed Web of Science ®Google Scholar
• Lee CH, Wang JY, Lin HC, et al. Treatment delay and fatal outcomes of pulmonary tuberculosis in advanced age: a retrospective nationwide cohort study. BMC Infect Dis. 2017;17:11.449. doi:10.1186/s12879-017-2554-y
   Web of Science ®Google Scholar
• Horton KC, MacPherson P, Houben R, White RG, Corbett EL. Sex differences in tuberculosis burden and notifications in low- and middle-income countries: a systematic review and meta-analysis. PLos Med. 2016;13(9):e1002119. doi:10.1371/journal.pmed.100211927598345
   PubMed Web of Science ®Google Scholar
• Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9(12):737–746. doi:10.1016/s1473-3099(09)70282-819926034
   PubMed Web of Science ®Google Scholar
• Wang CH, Yu CT, Lin HC, Liu CY, Kuo HP. Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuberc Lung Dis. 1999;79(4):235–242. doi:10.1054/tuld.1998.0167
   Google Scholar
• Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis Infection. New Engl J Med. 2015;372(22):2127–2135. doi:10.1056/NEJMra140542726017823
   PubMed Web of Science ®Google Scholar
• Nijland HMJ, Ruslami R, Stalenhoef JE, et al. Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis. 2006;43(7):848–854. doi:10.1086/50754316941365
   PubMed Web of Science ®Google Scholar
• Riccardi N, Villa S, Alagna R, et al. Advantages and challenges of tailored regimens for drug-resistant tuberculosis: a StopTB Italia look into the future. Infect Drug Resist. 2020;13:2795–2800. doi:10.2147/idr.S25748032848428
   PubMed Web of Science ®Google Scholar